Brandon T. Gufford

Identification of Diet-Derived Constituents as Potent Inhibitors of Intestinal Glucuronidation

Brandon T. Gufford, Gang Chen, Philip Lazarus et al. · Drug Metabolism and Disposition · 2014 · 44 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo

Brandon T. Gufford, Jessica Bo Li Lu, Ingrid F. Metzger et al. · Drug Metabolism and Disposition · 2016 · 35 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2<i>R</i>,6<i>R</i>)‐Hydroxynorketamine in Healthy Volunteers

Shruti M. Raja, Jeffrey T. Guptill, Michelle Mack et al. · Clinical Pharmacology & Therapeutics · 2024 · 33 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers

Andrea R. Masters, Brandon T. Gufford, Jessica Bo Li Lu et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 30 citations

Medicine, Pharmacokinetics, Pharmacology +15

Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product–Drug Interaction

Brandon T. Gufford, Gang Chen, Ana G. Vergara et al. · Drug Metabolism and Disposition · 2015 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13